These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34000272)

  • 21. Molecular basis for ligand modulation of the cannabinoid CB
    Ramesh K; Rosenbaum DM
    Br J Pharmacol; 2022 Jul; 179(14):3487-3495. PubMed ID: 34265078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors.
    Redmond WJ; Cawston EE; Grimsey NL; Stuart J; Edington AR; Glass M; Connor M
    Br J Pharmacol; 2016 Jan; 173(1):115-27. PubMed ID: 26398720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
    Leo LM; Abood ME
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.
    Khurana L; Mackie K; Piomelli D; Kendall DA
    Neuropharmacology; 2017 Sep; 124():3-12. PubMed ID: 28527758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
    Pertwee RG; Howlett AC; Abood ME; Alexander SP; Di Marzo V; Elphick MR; Greasley PJ; Hansen HS; Kunos G; Mackie K; Mechoulam R; Ross RA
    Pharmacol Rev; 2010 Dec; 62(4):588-631. PubMed ID: 21079038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.
    Laprairie RB; Bagher AM; Rourke JL; Zrein A; Cairns EA; Kelly MEM; Sinal CJ; Kulkarni PM; Thakur GA; Denovan-Wright EM
    Neuropharmacology; 2019 Jun; 151():1-12. PubMed ID: 30940536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modern approaches to the development of synthetic cannabinoid receptor probes.
    Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
    Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.
    Krishna Kumar K; Shalev-Benami M; Robertson MJ; Hu H; Banister SD; Hollingsworth SA; Latorraca NR; Kato HE; Hilger D; Maeda S; Weis WI; Farrens DL; Dror RO; Malhotra SV; Kobilka BK; Skiniotis G
    Cell; 2019 Jan; 176(3):448-458.e12. PubMed ID: 30639101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
    Rock EM; Sticht MA; Duncan M; Stott C; Parker LA
    Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
    Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical model.
    Green HM; Yang L; Zhu X; Finlay DB; Duffull SB; Glass M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5105-5118. PubMed ID: 38227196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
    Dopart R; Lu D; Lichtman AH; Kendall DA
    Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the profiles of CB
    Zhu X; Finlay DB; Glass M; Duffull SB
    Br J Pharmacol; 2020 Aug; 177(15):3449-3463. PubMed ID: 32293708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
    Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH
    Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery.
    Gado F; Meini S; Bertini S; Digiacomo M; Macchia M; Manera C
    Future Med Chem; 2019 Aug; 11(15):2019-2037. PubMed ID: 31517528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists.
    Patel M; Zheng X; Akinfiresoye LR; Prioleau C; Walker TD; Glass M; Marusich JA
    Eur J Pharmacol; 2024 May; 971():176549. PubMed ID: 38561104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G
    Hua T; Li X; Wu L; Iliopoulos-Tsoutsouvas C; Wang Y; Wu M; Shen L; Brust CA; Nikas SP; Song F; Song X; Yuan S; Sun Q; Wu Y; Jiang S; Grim TW; Benchama O; Stahl EL; Zvonok N; Zhao S; Bohn LM; Makriyannis A; Liu ZJ
    Cell; 2020 Feb; 180(4):655-665.e18. PubMed ID: 32004463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.